Anti-IOD2/ DIO2/ 5DII monoclonal antibody
Anti-IOD2/ DIO2/ 5DII antibody for FACS & in-vivo assay
Go to DIO2/DIO2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0359-Ab-1/ GM-Tg-hg-MP0359-Ab-2 | Anti-Human DIO2 monoclonal antibody | Human |
GM-Tg-rg-MP0359-Ab-1/ GM-Tg-rg-MP0359-Ab-2 | Anti-Rat DIO2 monoclonal antibody | Rat |
GM-Tg-mg-MP0359-Ab-1/ GM-Tg-mg-MP0359-Ab-2 | Anti-Mouse DIO2 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0359-Ab-1/ GM-Tg-cynog-MP0359-Ab-2 | Anti-Cynomolgus/ Rhesus macaque DIO2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0359-Ab-1/ GM-Tg-felg-MP0359-Ab-2 | Anti-Feline DIO2 monoclonal antibody | Feline |
GM-Tg-cang-MP0359-Ab-1/ GM-Tg-cang-MP0359-Ab-2 | Anti-Canine DIO2 monoclonal antibody | Canine |
GM-Tg-bovg-MP0359-Ab-1/ GM-Tg-bovg-MP0359-Ab-2 | Anti-Bovine DIO2 monoclonal antibody | Bovine |
GM-Tg-equg-MP0359-Ab-1/ GM-Tg-equg-MP0359-Ab-2 | Anti-Equine DIO2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0359-Ab-1/ GM-Tg-hg-MP0359-Ab-2; GM-Tg-rg-MP0359-Ab-1/ GM-Tg-rg-MP0359-Ab-2; GM-Tg-mg-MP0359-Ab-1/ GM-Tg-mg-MP0359-Ab-2; GM-Tg-cynog-MP0359-Ab-1/ GM-Tg-cynog-MP0359-Ab-2; GM-Tg-felg-MP0359-Ab-1/ GM-Tg-felg-MP0359-Ab-2; GM-Tg-cang-MP0359-Ab-1/ GM-Tg-cang-MP0359-Ab-2; GM-Tg-bovg-MP0359-Ab-1/ GM-Tg-bovg-MP0359-Ab-2; GM-Tg-equg-MP0359-Ab-1/ GM-Tg-equg-MP0359-Ab-2 |
Products Name | Anti-DIO2 monoclonal antibody |
Format | mab |
Target Name | DIO2 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-DIO2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species IOD2/ DIO2/ 5DII VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | vGMAD000267 | human DIO2 Adenovirus particle |
ORF Viral Vector | pGMAD000267 | human DIO2 Adenovirus plasmid |
ORF Viral Vector | pGMLPm001586 | mouse Dio2 Lentivirus plasmid |
ORF Viral Vector | vGMLPm001586 | mouse Dio2 Lentivirus particle |
Target information
Target ID | GM-MP0359 |
Target Name | DIO2 |
Gene ID | 1734,13371,65162,707484,490813,101088170,494548,100052547 |
Gene Symbol and Synonyms | 5DII,D2,DIO2,DIOII,SELENOY,SelY,TXDI2 |
Uniprot Accession | Q92813,P70551,Q5I3B2 |
Uniprot Entry Name | IOD2_HUMAN,IOD2_RAT,IOD2_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000211448 |
Target Classification | N/A |
The target: DIO2, gene name: DIO2, also named as 5DII, D2, DIOII, SelY, TXDI2. The protein encoded by this gene belongs to the iodothyronine deiodinase family. It catalyzes the conversion of prohormone thyroxine (3,5,3',5'-tetraiodothyronine, T4) to the bioactive thyroid hormone (3,5,3'-triiodothyronine, T3) by outer ring 5'-deiodination. This gene is widely expressed, including in thyroid and brain. It is thought to be responsible for the 'local' production of T3, and thus important in influencing thyroid hormone action in these tissues. It has also been reported to be highly expressed in thyroids of patients with Graves disease, and in follicular adenomas. The intrathyroidal T4 to T3 conversion by this enzyme may contribute significantly to the relative increase in thyroidal T3 production in these patients. This protein is a selenoprotein containing the non-standard amino acid, selenocysteine (Sec), which is encoded by the UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Unlike the other two members (DIO1 and DIO3) of this enzyme family, the mRNA for this gene contains an additional in-frame UGA codon that has been reported (in human) to function either as a Sec or a stop codon, which can result in two isoforms with one or two Sec residues; however, only the upstream Sec (conserved with the single Sec residue found at the active site in DIO1 and DIO3) was shown to be essential for enzyme activity (PMID:10403186). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2018].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.